Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
0.8400
-0.0942 (-10.08%)
At close: Jan 21, 2026, 4:00 PM EST
0.8300
-0.0100 (-1.19%)
After-hours: Jan 21, 2026, 7:56 PM EST
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $4.98 million as of January 21, 2026. Its market cap has decreased by -7.96% in one year.
Market Cap
4.98M
Enterprise Value
-7.73M
1-Year Change
-7.96%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $4.98M, a decrease of -94.50%. That is a compound annual growth rate of -42.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 4.98M | 5.03% |
| Dec 31, 2025 | 4.74M | 22.99% |
| Dec 31, 2024 | 3.85M | 22.18% |
| Dec 29, 2023 | 3.15M | -29.38% |
| Dec 30, 2022 | 4.46M | -93.27% |
| Dec 31, 2021 | 66.32M | -28.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 261.50B |